Roller R, Malik A, Carillo M, Garg M, Rella A, Raulf M
Angew Chem Int Ed Engl. 2020; 59(29):12035-12040.
PMID: 32307806
PMC: 7383966.
DOI: 10.1002/anie.202002479.
Dobrescu I, de Camargo T, Gimenez A, Murillo O, Amorim K, Marinho C
Front Immunol. 2020; 11:28.
PMID: 32153555
PMC: 7045055.
DOI: 10.3389/fimmu.2020.00028.
Lin C, Uboldi A, Epp C, Bujard H, Tsuboi T, Czabotar P
J Biol Chem. 2016; 291(14):7703-15.
PMID: 26823464
PMC: 4817195.
DOI: 10.1074/jbc.M115.698282.
Das S, Hertrich N, Perrin A, Withers-Martinez C, Collins C, Jones M
Cell Host Microbe. 2015; 18(4):433-44.
PMID: 26468747
PMC: 4608996.
DOI: 10.1016/j.chom.2015.09.007.
Simpalipan P, Pattaradilokrat S, Siripoon N, Seugorn A, Kaewthamasorn M, Butcher R
Malar J. 2014; 13:54.
PMID: 24521474
PMC: 3931489.
DOI: 10.1186/1475-2875-13-54.
Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
Cavanagh D, Kocken C, White J, Cowan G, Samuel K, Dubbeld M
PLoS One. 2014; 9(1):e83704.
PMID: 24421900
PMC: 3885447.
DOI: 10.1371/journal.pone.0083704.
Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands.
Badu K, Afrane Y, Larbi J, Stewart V, Waitumbi J, Angov E
BMC Infect Dis. 2012; 12:50.
PMID: 22380785
PMC: 3306741.
DOI: 10.1186/1471-2334-12-50.
Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
Forbes E, Biswas S, Collins K, Gilbert S, Hill A, Draper S
J Immunol. 2011; 187(7):3738-50.
PMID: 21876036
PMC: 3284248.
DOI: 10.4049/jimmunol.1003783.
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
Sheehy S, Duncan C, Elias S, Collins K, Ewer K, Spencer A
Mol Ther. 2011; 19(12):2269-76.
PMID: 21862998
PMC: 3242658.
DOI: 10.1038/mt.2011.176.
The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.
de Cassan S, Forbes E, Douglas A, Milicic A, Singh B, Gupta P
J Immunol. 2011; 187(5):2602-16.
PMID: 21813775
PMC: 3160495.
DOI: 10.4049/jimmunol.1101004.
Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques.
Kusi K, Remarque E, Riasat V, Walraven V, Thomas A, Faber B
Malar J. 2011; 10:182.
PMID: 21726452
PMC: 3142537.
DOI: 10.1186/1475-2875-10-182.
Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease.
de Monerri N, Flynn H, Campos M, Hackett F, Koussis K, Withers-Martinez C
Infect Immun. 2011; 79(3):1086-97.
PMID: 21220481
PMC: 3067499.
DOI: 10.1128/IAI.00902-10.
Fine specificity of anti-MSP119 antibodies and multiplicity of Plasmodium falciparum merozoite surface protein 1 types in individuals in Nigeria with sub-microscopic infection.
Ngoundou-Landji J, Nwuba R, Anumudu C, Odaibo A, Matondo Maya W, Awobode H
Malar J. 2010; 9:287.
PMID: 20955565
PMC: 2965716.
DOI: 10.1186/1475-2875-9-287.
Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth.
Child M, Epp C, Bujard H, Blackman M
Mol Microbiol. 2010; 78(1):187-202.
PMID: 20735778
PMC: 2995310.
DOI: 10.1111/j.1365-2958.2010.07324.x.
Advances and challenges in malaria vaccine development.
Wang R, Smith J, Kappe S
Expert Rev Mol Med. 2009; 11:e39.
PMID: 20003658
PMC: 2943423.
DOI: 10.1017/S1462399409001318.
A multifunctional serine protease primes the malaria parasite for red blood cell invasion.
Koussis K, Withers-Martinez C, Yeoh S, Child M, Hackett F, Knuepfer E
EMBO J. 2009; 28(6):725-35.
PMID: 19214190
PMC: 2647770.
DOI: 10.1038/emboj.2009.22.
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.
Draper S, Goodman A, Biswas S, Forbes E, Moore A, Gilbert S
Cell Host Microbe. 2009; 5(1):95-105.
PMID: 19154991
PMC: 2663714.
DOI: 10.1016/j.chom.2008.12.004.
Formation of the food vacuole in Plasmodium falciparum: a potential role for the 19 kDa fragment of merozoite surface protein 1 (MSP1(19)).
Dluzewski A, Ling I, Hopkins J, Grainger M, Margos G, Mitchell G
PLoS One. 2008; 3(8):e3085.
PMID: 18769730
PMC: 2518119.
DOI: 10.1371/journal.pone.0003085.
Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses.
Lyon J, Angov E, Fay M, Sullivan J, Girourd A, Robinson S
PLoS One. 2008; 3(7):e2830.
PMID: 18665258
PMC: 2474699.
DOI: 10.1371/journal.pone.0002830.
Modification of a human monoclonal antibody Fab fragment specific for Plasmodium falciparum 19-kDa C-terminal merozoite surface protein 1 by site-directed mutagenesis.
Tao Y, Cheng X, Fu Y, Tsukamoto H, Yoshihara E, Tachibana H
Parasitol Res. 2008; 103(2):429-33.
PMID: 18446371
DOI: 10.1007/s00436-008-0994-4.
